Resero Bio, Inc.
PrivateCompany Overview
Resero Bio, Inc. is a biotechnology company that develops a next-generation liquid biopsy platform using AI/ML-driven analytics to measure gene expression signals for cancer detection and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
liquid biopsycell-free RNAtranscriptomic profilingnext-generation sequencingNGSliquid biopsy testcancer diagnosticscfRNAprecision medicinecancer screeningbioinformaticstumor biologytherapeutic responsebiomarker discoveryclinical oncology
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resero Bio, Inc. Comparables
Compare Resero Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flomics Biotech | 82% | |
| Novigenix AI | 79% | |
| RealSeq Biosciences | 77% | |
Resero Bio, Inc. Funding Rounds
Historical fundraising activity
Resero Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resero Bio, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Carlos, California
Employee Range5
Year Founded2025
Last Funding—
See something wrong or outdated?